Penicillin-resistant pneumococci

Area of Science:

• Microbiology
• Infectious Diseases
• Pharmacology

Background:

• Penicillin-resistant Streptococcus pneumoniae (PRSP) poses a significant threat to treating respiratory tract infections.
• Current penicillin resistance in S. pneumoniae is predominantly relative, characterized by increased Minimum Inhibitory Concentrations (MICs).
• These isolates often remain susceptible to standard or high antibiotic doses.

Purpose of the Study:

• To explore strategies for minimizing the emergence of highly resistant Streptococcus pneumoniae strains.
• To identify antibiotics with high antipneumococcal activity and low resistance potential.
• To advise on the judicious use of vancomycin to prevent resistance.

Main Methods:

• Literature review and analysis of antibiotic resistance patterns.
• Evaluation of antibiotic activity against Streptococcus pneumoniae.
• Assessment of resistance potential for various antibiotic classes.

Main Results:

• Most penicillin resistance in S. pneumoniae is relative, allowing susceptibility to certain antibiotics at adequate doses.
• Antibiotics such as doxycycline, cefprozil, levofloxacin, cefepime, and meropenem exhibit high antipneumococcal activity and low resistance potential.
• Decreasing vancomycin use is crucial to mitigate the rise of vancomycin-resistant Enterococci (VRE) and vancomycin-intermediate Staphylococcus aureus.

Conclusions:

• Preferential use of antibiotics with favorable resistance profiles can curb the development of highly resistant pneumococci.
• Judicious antibiotic selection is key to effective treatment of respiratory infections and antimicrobial stewardship.
• Careful monitoring and reduced reliance on vancomycin are necessary to preserve its efficacy and prevent broader resistance issues.